Hydroxyzine Pamoate

CHEMBL1200467 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
763.3 g/mol
LogP
Phase
4

This pamoate salt form of hydroxyzine is used in capsule form for anxiety and tension relief, as well as allergic conditions. The pamoate salt allows for a slightly different absorption profile compared to the hydrochloride salt. Like other hydroxyzine formulations, it carries anticholinergic side effects including dry mouth and drowsiness.

Khối lượng phân tử

763,3000 g/mol

TPSA

151,00 Ų

Lĩnh vực điều trị

Cơ chế tác dụng

Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C(O)c1cc2ccccc2c(Cc2c(O)c(C(=O)O)cc3ccccc23)c1O.OCCOCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1

InChI

InChI=1S/C23H16O6.C21H27ClN2O2/c24-20-16(14-7-3-1-5-12(14)9-18(20)22(26)27)11-17-15-8-4-2-6-13(15)10-19(21(17)25)23(28)29;22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-10,24-25H,11H2,(H,26,27)(H,28,29);1-9,21,25H,10-17H2

Molecular Formula

C44H43ClN2O8

HBD / HBA

5 / 10

Liên kết có thể quay

12

Nguyên tử nặng

55

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

This pamoate salt form of hydroxyzine is used in capsule form for anxiety and tension relief, as well as allergic conditions. The pamoate salt allows for a slightly different absorption profile compared to the hydrochloride salt. Like other hydroxyzine formulations, it carries anticholinergic side effects including dry mouth and drowsiness.

Competitively blocks muscarinic acetylcholine receptors, reducing parasympathetic nervous system activity. Effects include decreased secretions, bronchodilation, and relaxation of smooth muscle.

Yes, Hydroxyzine Pamoate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200467. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 25096. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.